Claims
- 1. A compound of the formula ##STR141## wherein R.sup.1 is C.sub.1 -C.sub.6 alkyl or cycloalkylmethyl of the formula --CH.sub.2 OH<(CH.sub.2).sub.n in which n is an integer in the range 2-5;
- R.sup.2 is ##STR142## A is hydrogen or hydroxyl; Ar is ##STR143## in which R.sup.3 is hydrogen, hydroxyl, methoxyl or acetoxyl;
- R.sup.4 is hydroxyl, methoxyl or acetoxyl; and jointly, two of R.sup.3 or of R.sup.4 situated on adjacent carbons may be combined to form a divalent methylenedioxy (--OCH.sub.2 O--) group; provided that when R.sup.1 =methyl, R.sup.3 may not both be hydrogen.
- 2. A compound according to claim 1 which is dextrorotatory.
- 3. A compound according to claim 1 which is laevorotatory.
- 4. The compound N-methyl-4a(m-methoxyphenyl)-trans-decahydroisoquinoline.
- 5. The compound N-methyl-4a-(m-hydroxyphenyl)-trans-decahydroisoquinoline.
- 6. The compound N-methyl-4a-phenyl-8a-hydroxy-trans-decahydroisoquinoline.
- 7. The compound of claim 1 which is N-cyclohexylmethyl-4a-phenyl-trans-decahydroisoquinoline.
- 8. The compound of claim 1 which is N-cyclopropylmethyl-4a-(m-methoxyphenyl)-trans-decahydroisoquinoline.
- 9. The compound of claim 1 which is N-cyclopropylmethyl-4a-(m-hydroxyphenyl)-trans-decahydroisoquinoline.
- 10. The compound of claim 1 which is N-(n-hexyl)-4a-(m-hydroxyphenyl)-trans-decahydroisoquinoline.
- 11. The compound of claim 1 which is N-cyclopropylmethyl-4a-(m-methoxyphenyl)-6-methyl-trans-decahydroisoquinoline.
- 12. The compound of claim 1 which is N-cyclopropylmethyl-4a-(m-hydroxyphenyl)-6-methyl-trans-decahydroisoquinoline.
- 13. A compound of the formula ##STR144## in which R is --OH or --OCH.sub.3 ; and
- R.sup.1 is alkyl of 1-6 carbon atoms; inclusive, or a pharmaceutically suitable salt thereof.
- 14. A compound of the formula ##STR145## wherein R is cyclopropylmethyl or cyclobutylmethyl;
- R.sup.1 is hydroxyl, methoxyl or acetoxyl; and pharmaceutically-acceptable acid addition salts thereof.
- 15. A compound according to claim 14 in which R' is OH.
- 16. A compound according to claim 14 in which R.sup.1 is methoxyl.
- 17. A compound according to claim 14 in which R is cyclopropylmethyl.
- 18. A compound according to claim 14, said compound being trans-dl-1-cyclobutylmethyl-3a-(m-hydroxyphenyl)-1,2,3,3a,4,5,6,7a,8-decahydroisoquinoline.
- 19. A compound according to claim 14, said compound being trans-dl-1-cyclopropylmethyl-3a(m-hydroxyphenyl)-1,2,3,3a,4,5,6,7,7a,8-decahydroisoquinoline.
- 20. A compound according to claim 14, said compound being trans-1(-)-1-cyclopropylmethyl-3a-(m-hydroxyphenyl)-1,2,3,3a,4,5,6,7,7a,8-decahydroisoquinoline.
- 21. A trans-dl racemate of a compound according to claim 14.
- 22. A trans-dl racemate of a compound according to claim 14 in which R.sup.1 is OH.
RELATED APPLICATION
This application is a continuation-in-part of patent application Ser. No. 365,843 filed June 1, 1973, now abandoned which is a continuation-in-part of patent application Ser. No. 273,806 filed July 20, 1972, now abandoned.
US Referenced Citations (15)
Foreign Referenced Citations (1)
Number |
Date |
Country |
1164192 |
Aug 1966 |
GBX |
Non-Patent Literature Citations (2)
Entry |
Boekelheide et al. "J.A.C.S.," 72, 712 (1950). |
Eddy "J. of the Am. Pharm. Assoc." 1950, pp. 245 ff. |
Continuation in Parts (2)
|
Number |
Date |
Country |
Parent |
365843 |
Jun 1973 |
|
Parent |
273806 |
Jul 1972 |
|